Talk Abstract Parallel track
Therapeutic Strategies in MASH: Incretins, Metabolic Modulators, and Novel Approaches
Sat, Nov 7, 2026 · 8:00–9:30 AM MST Convention Center: Bluebird Ballroom 1A, Colorado Convention Center
About this session
This session will examine evolving therapeutic approaches for metabolic dysfunction-associated steatohepatitis, with emphasis on pharmacologic and mechanistic interventions targeting steatohepatitis, fibrosis, metabolic dysfunction, and cirrhosis. Together, these studies showcase the expanding treatment landscape for MASH across disease stages, fibrosis severity, cardiometabolic subgroups, and emerging therapeutic mechanisms.
Speaker
Reviews of this session
No reviews yet
Were you in the room? Reviews are open until Nov 9, 2027.